|
UNITED STATES |
||
|
________________________________ |
||
|
FORM 8-K |
||
|
CURRENT REPORT |
||
|
PURSUANT TO SECTION 13 OR 15(d) OF THE |
||
|
DATE OF REPORT (Date of earliest event reported): November 14, 2008 |
||
|
IGI LABORATORIES, INC. |
||
|
(Exact name of registrant as specified in charter) |
||
|
DELAWARE |
001-08568 |
01-0355758 |
|
(State or Other Jurisdiction of |
(Commission |
(I.R.S. Employer |
|
Incorporation) |
file number) |
Identification Number) |
|
105 Lincoln Avenue |
|
|
Buena, New Jersey 08310 |
|
|
(Address of principal executive offices)(Zip Code) |
|
|
(856) 697-1441 |
|
|
(Registrant's telephone number, including area code) |
|
|
Not Applicable |
|
|
(Former name or former address, if changed since last report) |
|
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: |
|
|
[ ] |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
[ ] |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
[ ] |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act |
|
[ ] |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act |
<PAGE>
|
Item 2.02. |
Results of Operations and Financial Condition. |
|
On November 14, 2008, IGI Laboratories, Inc. (the "Company") issued a press release announcing the Company's earnings for the third quarter ended September 30, 2008 and certain other information. A copy of the press release is attached hereto as Exhibit 99.1. The press release is being furnished and shall not be deemed to be filed. |
|
|
Item 9.01. |
Financial Statements and Exhibits. |
|
(d) Exhibits |
|
|
Exhibit Number |
Description of Exhibit |
|
Exhibit 99.1 |
IGI Laboratories, Inc. Press Release dated November 14, 2008 |
<PAGE>
|
SIGNATURE |
||
|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. |
||
|
IGI, INC. |
||
|
Date: November 14, 2008 |
By: /s/ Justine Kostka |
|
|
|
||
|
Name: Justine Kostka |
||
|
Title: Acting Principal |
||
<PAGE>
|
EXHIBIT INDEX |
|
Exhibit Number |
Description of Exhibit |
|
99.1 |
IGI Laboratories, Inc. Press Release dated November 14, 2008 |